Benzinga’s Volume Movers (GENZ, OSIS, DCTH, ADTN)

Genzyme Corp

shares gained 4.85% to $50.83 by 12:48 pm. The volume of GENZ shares traded was 383% higher than normal. GENZ’s Lumizyme has received FDA approval as a treatment for Pompe disease, a rare genetic disorder. OSI Systems Inc

shares climbed 4.31% to $25.63 by 12:48 pm. The volume of OSIS shares traded was 131% higher than normal. OSIS’ security division, Rapiscan Systems, received approximately $3 million in initial contract awards to supply air cargo inspection systems to two major international airlines. Delcath Systems Inc

shares jumped 3.43% to $15.07. The volume of DCTH shares traded was 85% higher than normal. Roth Capital initiated coverage of DCTH with a “buy” rating. ADTRAN Inc

shares rose 5.03% to $ 26.93. The volume of ADTN shares traded was 84% higher than normal. ADTN posted better-than-expected earnings for the March quarter. Read more